Shelly Guest Cermak

Array ( [id] => 3482760 [patent_doc_number] => 05405945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-11 [patent_title] => 'DNA encoding reproductive hormones and expression using a minigene' [patent_app_type] => 1 [patent_app_number] => 7/950835 [patent_app_country] => US [patent_app_date] => 1992-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 11069 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/405/05405945.pdf [firstpage_image] =>[orig_patent_app_number] => 950835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3059433 [patent_doc_number] => 05338835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-16 [patent_title] => 'CTP-extended form of FSH' [patent_app_type] => 1 [patent_app_number] => 7/950801 [patent_app_country] => US [patent_app_date] => 1992-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 11076 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/338/05338835.pdf [firstpage_image] =>[orig_patent_app_number] => 950801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3022290 [patent_doc_number] => 05326860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-05 [patent_title] => 'Pituitary adenylate cyclase activating protein precursor' [patent_app_type] => 1 [patent_app_number] => 7/940443 [patent_app_country] => US [patent_app_date] => 1992-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6386 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/326/05326860.pdf [firstpage_image] =>[orig_patent_app_number] => 940443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3445961 [patent_doc_number] => 05387520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-07 [patent_title] => 'Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/936923 [patent_app_country] => US [patent_app_date] => 1992-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 7245 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/387/05387520.pdf [firstpage_image] =>[orig_patent_app_number] => 936923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2955833 [patent_doc_number] => 05231176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-27 [patent_title] => 'Distinct family DNA encoding of human leukocyte interferons' [patent_app_type] => 1 [patent_app_number] => 7/895902 [patent_app_country] => US [patent_app_date] => 1992-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6066 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/231/05231176.pdf [firstpage_image] =>[orig_patent_app_number] => 895902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2944019 [patent_doc_number] => 05223611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-29 [patent_title] => 'DNA encoding for human GP130 protein' [patent_app_type] => 1 [patent_app_number] => 7/889131 [patent_app_country] => US [patent_app_date] => 1992-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 5352 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/223/05223611.pdf [firstpage_image] =>[orig_patent_app_number] => 889131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3455066 [patent_doc_number] => 05451669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-19 [patent_title] => 'DNA encoding for an Fc receptor for immunoglobulin' [patent_app_type] => 1 [patent_app_number] => 7/896457 [patent_app_country] => US [patent_app_date] => 1992-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 11634 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/451/05451669.pdf [firstpage_image] =>[orig_patent_app_number] => 896457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3101262 [patent_doc_number] => 05315000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-24 [patent_title] => 'Gene encoding for a L5/3 growth factor and its CDNA' [patent_app_type] => 1 [patent_app_number] => 7/882925 [patent_app_country] => US [patent_app_date] => 1992-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8812 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/315/05315000.pdf [firstpage_image] =>[orig_patent_app_number] => 882925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3414665 [patent_doc_number] => 05444164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'TGF-.beta. induced gene' [patent_app_type] => 1 [patent_app_number] => 7/878960 [patent_app_country] => US [patent_app_date] => 1992-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 5777 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/444/05444164.pdf [firstpage_image] =>[orig_patent_app_number] => 878960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2891030 [patent_doc_number] => 05239058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-24 [patent_title] => 'Proteins having anticoagulant properties' [patent_app_type] => 1 [patent_app_number] => 7/876825 [patent_app_country] => US [patent_app_date] => 1992-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12167 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/239/05239058.pdf [firstpage_image] =>[orig_patent_app_number] => 876825 [rel_patent_id] =>[rel_patent_doc_number] =>)